CHMP5 and COVID-19: There was a significant difference in α-Spike-Ab concentrations between mild and critically infected COVID-19 patients who died from SARS-CoV-2 infection (pd1 = 0.005, pd8 = 0.0006, pd15 = 0.001, Figure 1E) and those patients who survived COVID-19 (pd1 = 0.04, pd8 = 0.004, pd15 = 0.03, Figure 1E).